Sarepta Therapeutics, Inc. (BMV:SRPT)
Mexico flag Mexico · Delayed Price · Currency is MXN
725.01
0.00 (0.00%)
Last updated: May 12, 2025
Market Cap 70.19B
Revenue (ttm) 45.65B
Net Income (ttm) -5.08B
Shares Out n/a
EPS (ttm) -52.93
PE Ratio n/a
Forward PE 6.33
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 56
Open 725.01
Previous Close 725.01
Day's Range 725.01 - 725.01
52-Week Range 725.00 - 2,501.45
Beta n/a
RSI 7.51
Earnings Date May 6, 2025

About Sarepta Therapeutics

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 1,372
Stock Exchange Mexican Stock Exchange
Ticker Symbol SRPT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.